CRISPR Therapeutics' revenue streams currently rely heavily on grants and collaboration revenues from its partnership with Vertex Pharmaceuticals (VRTX). The collaboration has yielded Casgevy, a ...

This is an important study utilizing innovative CRISPR based approaches demonstrating the role of the KLF family of transcription factors in the post natal maturation of cortical projection neurons.

The question we face isn’t whether AI will carry forward our memories. It already does. The real question is whether we have ...

Repare Therapeutics Inc.’s RPTX share price has surged by 5.60%, which has investors questioning if this is right time to ...

Joanna Sugden is a foreign news editor for The Wall Street Journal based in London.

Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly interspaced ...

Gene therapy developer CRISPR Therapeutics AG (CRSP) is navigating some regulatory and commercial dynamics. Its flagship gene ...

Some Black churches are pledging to support the National Museum of African American History and Culture following an ...

Modalis Therapeutics Corp. advanced stock charts by Barron's. View 4883 historical stock data and compare to other stocks, and exchanges.

It sounds like science fiction—but with CRISPR gene editing and ancient DNA research advancing rapidly, the idea of bringing ...

The U.S. State Department says North Korea has an offensive biological weapons program that dates back at least to the 1960s. In a report titled Adherence to and Compliance ...

Twist Bioscience Corporation’s TWST share price has dipped by 5.86%, which has investors questioning if this is right time to ...